Replies to post #637270 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Care providers have discretion, such as in the case of unmethylated GBM patients, whether or not to use chemo as part of SOC.

In the phase iii trial, chemo was not used in DCVax-l trial after cross-over.